Tag: NASDAQ:ESPR

Esperion Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $227.0 on

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Esperion Therapeutics Inc.’s filing revealed that its President and CEO Koenig Sheldon L. unloaded Company’s shares for reported $26132.0 on